Developer of robotic-assisted surgical systems used in minimally invasive procedures, focused on hospitals seeking alternatives to higher-cost robotic platforms. The company’s Senhance system integrates robotics, eye-tracking, and digital laparoscopy technologies aimed at improving precision and con...
No congressional trades have been disclosed for TransEnterix, Inc. (TRXC) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.